Showing 2 of 2 recruiting trials for “crigler-najjar-syndrome-type-2”
Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome
👨⚕️ Philippe LABRUNE, MD, PHD, APHP_Hopital Antoine BECLERE📍 1 site📅 Started Nov 2024View details ↗
Gene Therapy for Severe Crigler Najjar Syndrome
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →